JP2011172797A - Ascites treatment system and cleaning method thereof - Google Patents

Ascites treatment system and cleaning method thereof Download PDF

Info

Publication number
JP2011172797A
JP2011172797A JP2010040109A JP2010040109A JP2011172797A JP 2011172797 A JP2011172797 A JP 2011172797A JP 2010040109 A JP2010040109 A JP 2010040109A JP 2010040109 A JP2010040109 A JP 2010040109A JP 2011172797 A JP2011172797 A JP 2011172797A
Authority
JP
Japan
Prior art keywords
ascites
filter
cleaning
treatment system
cleaning liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010040109A
Other languages
Japanese (ja)
Other versions
JP5249973B2 (en
Inventor
Keisuke Matsuzaki
圭祐 松崎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2010040109A priority Critical patent/JP5249973B2/en
Publication of JP2011172797A publication Critical patent/JP2011172797A/en
Application granted granted Critical
Publication of JP5249973B2 publication Critical patent/JP5249973B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

<P>PROBLEM TO BE SOLVED: To provide an ascites treatment system for treating a large amount of ascites by easily cleaning a filter in a short period of time. <P>SOLUTION: The ascites treatment system (1) includes: the filter (3) having a filter member (35) for selectively removing a specific substance in the ascites; and a concentrator (5) which is connected to the ascites discharge port (3b) of the filter (3) via a filter ascites transfer passage (19) and filters and concentrates the filtered ascites (A2) filtered by the filter. The filter (3) includes: a cleaning liquid supply port (3c) through which a cleaning liquid (CL) is supplied to the filter member (35) from an external part during the cleaning of the ascites treatment system in which the filter ascites transfer passage is blocked; and a cleaning waste liquid discharge port (3e) for discharging the substance (61) selectively removed by the filter member together with the cleaning liquid when cleaning. <P>COPYRIGHT: (C)2011,JPO&INPIT

Description

本発明は、患者から採取した腹水から有害物質を除去して患者の体内に戻すために、腹水を濾過・濃縮処理して回収する腹水処理システム、および、当該システムを洗浄する方法に関する。   The present invention relates to an ascites treatment system for collecting and collecting ascites by filtering and concentrating it in order to remove harmful substances from the ascites collected from the patient and return them to the body of the patient, and a method for cleaning the system.

近年、肝硬変、内臓病、癌性腹膜炎などでみられる難治性腹水に対して、腹水中の有害物質である細菌やガン細胞などの細胞成分を除去し、有用物質であるアルブミンなどの自己蛋白質を濃縮して患者に再利用する腹水濾過濃縮再静注治療が、ガン治療や緩和医療の一環として行われている。かかる治療法において腹水を濾過・濃縮処理するための装置として、腹水から有害物質を除去する濾過器および腹水を濃縮する濃縮器の上流側から、送液用ポンプによって腹水を送液するとともに、濃縮器の濃縮膜に真空ポンプなどにより陰圧を加え、濃縮器での濃縮膜における圧力勾配のみによる限外ろ過作用を利用して腹水の濃縮回収を行う腹水処理システムが知られている(例えば、特許文献1及び2)。   In recent years, for intractable ascites found in cirrhosis, visceral disease, cancerous peritonitis, etc., cell components such as bacteria and cancer cells that are harmful substances in ascites are removed, and self-proteins such as albumin that are useful substances are removed. Concentrated and reused ascites filtered concentrated re-injection treatment for recycle to patients is performed as part of cancer treatment and palliative treatment. As a device for filtering and concentrating ascites in such a treatment method, ascites is fed from a filter for removing harmful substances from ascites and a concentrator for concentrating ascites from the upstream side of the ascites and concentrated. An ascites treatment system is known in which negative pressure is applied to the concentrator membrane using a vacuum pump or the like, and the ascites is concentrated and recovered using only the ultrafiltration effect due to the pressure gradient in the concentrator membrane (for example, Patent Documents 1 and 2).

特開昭55−16674号公報JP-A-55-16664 特開昭57−31867号公報JP 57-31867 A

しかしながら、このような従来のシステムでは、腹水の濾過過程で、濾過膜の表面にガン細胞や血球、フィブリンなどの除去された物質が付着することにより、短時間で濾過膜の孔が閉塞される。したがって、例えば、1〜3L程度の腹水を処理しただけで濾過膜が閉塞する場合があり、大量の腹水を継続的に処理することが困難であった。。   However, in such a conventional system, the pores of the filtration membrane are blocked in a short time due to the removal of cancer cells, blood cells, fibrin and the like attached to the surface of the filtration membrane during the filtration of ascites. . Therefore, for example, the filtration membrane may be blocked only by treating about 1 to 3 L of ascites, and it has been difficult to continuously treat a large amount of ascites. .

本発明は上記課題に鑑みてなされたものであって、その目的とするところは、濾過器の洗浄を短時間で、かつ容易に行うことができる構成を備えることにより、大量の腹水を短時間に処理することが可能な腹水処理システム、および、該システムの洗浄方法を提供することにある。   This invention is made | formed in view of the said subject, The place made into the objective is providing a structure which can perform the washing | cleaning of a filter in a short time and easily, and a large amount of ascites is made in a short time. It is an object of the present invention to provide an ascites treatment system that can be treated and a method for cleaning the system.

前記した目的を達成するために、本発明に係る腹水処理システムは、腹水中の特定の物質を選択的に除去する濾過部材を備える濾過器と、前記濾過器の腹水排出ポートに濾過腹水移送路を介して接続し、前記濾過器で濾過された濾過腹水を濾過して濃縮する濃縮器とを備え、前記濾過器は、前記濾過腹水移送路が遮断された該腹水処理システムの洗浄時に、外部から濾過部材に洗浄液が供給される洗浄液供給ポートと、前記濾過部材によって選択的に除去された物質を前記洗浄時に前記洗浄液とともに排出する洗浄廃液排出ポートとを有する。   In order to achieve the above-described object, an ascites treatment system according to the present invention includes a filter including a filter member that selectively removes a specific substance in ascites, and a filter ascites transfer path to the ascites discharge port of the filter. And a concentrator for filtering and concentrating the filtered ascites filtered through the filter, and the filter is externally disposed during the cleaning of the ascites treatment system in which the filtration ascites transfer path is blocked. A cleaning liquid supply port through which the cleaning liquid is supplied to the filtration member, and a cleaning waste liquid discharge port for discharging the material selectively removed by the filtration member together with the cleaning liquid during the cleaning.

この構成によれば、濾過器を短時間に洗浄することができるので、適宜洗浄を行いながら継続的に大量の腹水を処理することが可能となる。さらに、膜の目詰まりを起こし易い、細胞成分や粘液成分を多く含む腹水や血性腹水を処理することも可能となる。   According to this configuration, since the filter can be washed in a short time, a large amount of ascites can be treated continuously while appropriately washing. Furthermore, it becomes possible to treat ascites or bloody ascites containing a large amount of cell components and mucus components, which easily cause clogging of the membrane.

本発明の一実施形態に係る腹水処理システムにおいて、前記濾過器の前記濾過部材が中空糸膜であり、外圧方式で両端が開口した中空糸膜の一端部が腹水処理時に閉塞される前記洗浄液供給ポートに連通しており、他端部が前記腹水排出ポートに連通していることが好ましい。腹水処理における濾過部材として中空糸膜を使用し、濾過器を外圧方式の濾過装置として構成することにより、膜の外表面に付着した細胞成分などの物質を、膜の内側から外側に向かって剥離させることができる。その結果、濾過部材の効果的な洗浄が可能となり、かつ、効果的に腹水の処理を行うことができる。   In the ascites treatment system according to one embodiment of the present invention, the cleaning liquid supply is such that the filtration member of the filter is a hollow fiber membrane, and one end of the hollow fiber membrane that is open at both ends by an external pressure method is closed during ascites treatment It is preferable that the port communicates with the other end and communicates with the ascites discharge port. By using a hollow fiber membrane as a filtration member in ascites treatment and configuring the filter as an external pressure filtration device, substances such as cell components attached to the outer surface of the membrane are peeled from the inside to the outside of the membrane. Can be made. As a result, the filter member can be effectively cleaned and the ascites can be effectively treated.

本発明の一実施形態に係る腹水処理システムにおいて、さらに、前記洗浄時に、前記濾過器に前記洗浄液を供給する洗浄液供給器と、前記濾過器から排出された前記洗浄廃液を回収する洗浄廃液回収容器とを有していてもよい。この構成によれば、濾過器の洗浄を一層容易に行うことができる。   In the ascites treatment system according to an embodiment of the present invention, a cleaning liquid supplier that supplies the cleaning liquid to the filter during the cleaning, and a cleaning waste liquid collection container that recovers the cleaning waste liquid discharged from the filter You may have. According to this configuration, the filter can be more easily cleaned.

また、上記した目的を達成するために、本発明に係る腹水処理装置の洗浄方法は、前記濾過腹水移送路を遮断することと、前記濾過器に外部から前記洗浄液を供給することと、前記濾過部材によって選択的に除去された物質を、前記洗浄液とともに排出することとを含む。この構成によれば、短時間で用意に濾過部材の洗浄を行うことができるので、当該腹水処理システムにより大量の腹水を処理することが可能となる。   In order to achieve the above object, the ascites treatment apparatus cleaning method according to the present invention includes: cutting off the filtered ascites transfer path; supplying the cleaning liquid from the outside to the filter; Discharging the substance selectively removed by the member together with the cleaning liquid. According to this configuration, since the filtration member can be prepared in a short time, a large amount of ascites can be treated by the ascites treatment system.

このように、本発明に係る腹水処理システムおよび腹水処理方法によれば、短時間で容易に濾過器の洗浄を行うことができるので、大量の腹水を継続的に処理することが可能となる。   Thus, according to the ascites treatment system and the ascites treatment method according to the present invention, the filter can be easily washed in a short time, so that a large amount of ascites can be treated continuously.

本発明の一実施形態に係る腹水処理システムを示す概略構成図である。It is a schematic block diagram which shows the ascites processing system which concerns on one Embodiment of this invention. 図1の腹水処理システムに用いられる濾過器を示す縦断面図である。It is a longitudinal cross-sectional view which shows the filter used for the ascites processing system of FIG. 図1の腹水処理システムの洗浄方法の原理を示す断面図である。It is sectional drawing which shows the principle of the washing | cleaning method of the ascites processing system of FIG.

以下、本発明に係る実施形態を図面に従って説明するが、本発明はこの実施形態に限定されるものではない。   Hereinafter, embodiments according to the present invention will be described with reference to the drawings. However, the present invention is not limited to the embodiments.

図1は、本発明の一実施形態に係る腹水処理システム1の構成を示す概略図である。この腹水処理システム1は、人体から採取した腹水から有害物質を除去して患者の体内に戻すために、腹水を濾過・濃縮処理して回収するためのシステムであり、主要な構成要素として、濾過器3、濃縮器5、遮断器7、洗浄液供給器9および洗浄廃液回収容器11を備えている。濾過器3の上流部には、処理対象の腹水A1を貯留する貯留容器13が接続され、濃縮器5には処理済みの腹水A3を回収する回収容器15が接続されている。   FIG. 1 is a schematic diagram showing a configuration of an ascites treatment system 1 according to an embodiment of the present invention. This ascites treatment system 1 is a system for collecting and collecting ascites by filtering and concentrating to remove harmful substances from the ascites collected from the human body and returning them to the patient's body. A container 3, a concentrator 5, a circuit breaker 7, a cleaning liquid supplier 9 and a cleaning waste liquid recovery container 11 are provided. A storage container 13 for storing the ascites A1 to be processed is connected to the upstream portion of the filter 3, and a collection container 15 for recovering the processed ascites A3 is connected to the concentrator 5.

人体から採取した腹水A1は、まず貯留容器13に貯留され、貯留容器13から腹水A1が供給される。貯留容器13の下流には、濾過器3が、連通路を形成する第1連通チューブ17を介して接続されている。第1連通チューブ17の中途には、開放弁18が設けられている。さらに、濾過器3の下流には、濾過器3で濾過された濾過腹水A2の移送路を形成する第2連通チューブ19を介して、濃縮器5が接続されている。すなわち、貯留容器13から腹水A1を排出する腹水供給ポート13aと、濾過器3に貯留容器13からの腹水A1を導入する腹水導入ポート3aとが、第1連通チューブ17を介して接続されており、さらに、濾過腹水A2を排出する腹水排出ポート3bと、濃縮器5に濾過腹水A2を導入する濾過腹水導入ポート5aとが、第2連通チューブ19を介して接続されている。   Ascites A1 collected from the human body is first stored in the storage container 13, and the ascites A1 is supplied from the storage container 13. Downstream of the storage container 13, the filter 3 is connected via a first communication tube 17 that forms a communication path. An open valve 18 is provided in the middle of the first communication tube 17. Further, the concentrator 5 is connected to the downstream of the filter 3 via a second communication tube 19 that forms a transfer path for the filtered ascites A2 filtered by the filter 3. That is, the ascites supply port 13 a for discharging the ascites A1 from the storage container 13 and the ascites introduction port 3 a for introducing the ascites A1 from the storage container 13 to the filter 3 are connected via the first communication tube 17. Furthermore, an ascites discharge port 3 b for discharging the filtered ascites A 2 and a filtered ascites introduction port 5 a for introducing the filtered ascites A 2 into the concentrator 5 are connected via the second communication tube 19.

濃縮器5の下流側には、廃液を排出する廃液ポート5bと、濃縮器5で濃縮処理された濃縮腹水A3を排出する回収ポート5cとが設けられている。廃液ポート5bには、濃縮器5から廃液Wを吸引するための廃液吸引装置21が、廃液通路を形成する廃液チューブ23を介して接続されている。一方、回収ポート5cには、濃縮腹水A3を回収するための回収容器15が、回収通路を形成する回収チューブ25を介して接続されている。さらに、回収チューブ25の中途には、陰圧を発生させる陰圧発生装置27が配設されている。   On the downstream side of the concentrator 5, a waste liquid port 5b for discharging the waste liquid and a recovery port 5c for discharging the concentrated ascites A3 concentrated by the concentrator 5 are provided. A waste liquid suction device 21 for sucking the waste liquid W from the concentrator 5 is connected to the waste liquid port 5b via a waste liquid tube 23 that forms a waste liquid passage. On the other hand, a collection container 15 for collecting the concentrated ascites A3 is connected to the collection port 5c via a collection tube 25 that forms a collection passage. Further, a negative pressure generating device 27 that generates a negative pressure is disposed in the middle of the collection tube 25.

また、廃液チューブ23の中途には、陰圧開放通路を形成する陰圧開放チューブ29が接続されている。陰圧開放チューブ29は、チューブ内と外部とを連通させることが可能な開放弁31を有している。   Further, in the middle of the waste liquid tube 23, a negative pressure release tube 29 that forms a negative pressure release passage is connected. The negative pressure release tube 29 has an open valve 31 capable of communicating the inside of the tube with the outside.

濾過器3は、濾過により、腹水A1中の細菌やガン細胞などの有害物質を選択的に除去するための装置である。濾過器3としては、腹水A1中の有用物質であるアルブミン、グロブリン等のタンパク質を通過させ、かつ、上記有害物質を捕捉することのできるものであればどのようなものを用いてもよいが、本実施形態においては、樹脂製の筒状の濾過器ハウジング33内に、濾過部材として最大孔径約0.2μmの中空糸膜35を複数束にして収容したものを用いている。濾過器3は、後に詳述するように、中空糸膜35を濾過部材とする外圧濾過式の濾過装置として構成されている。   The filter 3 is a device for selectively removing harmful substances such as bacteria and cancer cells in the ascites A1 by filtration. As the filter 3, any substance can be used as long as it can pass proteins such as albumin and globulin, which are useful substances in the ascites A1, and can capture the harmful substances. In the present embodiment, a plurality of hollow fiber membranes 35 having a maximum pore diameter of about 0.2 μm are housed in a resin cylindrical filter housing 33 as a filtering member. As will be described in detail later, the filter 3 is configured as an external pressure filtration type filtration device using the hollow fiber membrane 35 as a filtration member.

濾過器3に用いる濾過部材としては、中空糸膜35のほかに平膜を用いることもできるが、単位体積あたりの膜面積をより大きく取ることができ、かつ表面に付着した除去物質の洗浄が容易にできるという観点から、多孔性の中空糸膜が好ましく用いられる。濾過器3に使用する中空糸膜の素材には特に制限はないが、実用性のある強度および耐圧性を有し、滅菌が可能であるポリスルホン、ポリエチレン、ポリプロピレン、ポリビニルアルコール、エチレン−ビニルアルコール共重合体などが好ましく使用される。   As a filtration member used for the filter 3, a flat membrane can be used in addition to the hollow fiber membrane 35. However, the membrane area per unit volume can be increased, and the removed substance adhering to the surface can be washed. A porous hollow fiber membrane is preferably used from the viewpoint that it can be easily formed. The material of the hollow fiber membrane used for the filter 3 is not particularly limited, but it has practical strength and pressure resistance and can be sterilized with polysulfone, polyethylene, polypropylene, polyvinyl alcohol, and ethylene-vinyl alcohol. A polymer or the like is preferably used.

本実施形態における濾過器3は、その上流側の端部に洗浄液導入ポート3cが設けられており、この洗浄液導入ポート3cに、洗浄液導入通路を形成する洗浄液導入チューブ37を介して、洗浄液供給器9が接続されている。洗浄液導入チューブ37の中途には、開放弁39が設けられている。洗浄液供給器9としては、洗浄液CLを貯留し、洗浄液CLに圧力をかけて吐出することができればどのようなものを用いてもよいが、本実施形態ではシリンジを使用している。洗浄液CLとしては、浸透圧によって細胞が破壊されない液体を使用することができ、例えば、生理食塩水が好ましく用いられる。   The filter 3 in the present embodiment is provided with a cleaning liquid introduction port 3c at an upstream end thereof, and a cleaning liquid supply device is connected to the cleaning liquid introduction port 3c via a cleaning liquid introduction tube 37 forming a cleaning liquid introduction passage. 9 is connected. An opening valve 39 is provided in the middle of the cleaning liquid introduction tube 37. As the cleaning liquid supply device 9, any cleaning liquid CL may be used as long as it stores the cleaning liquid CL and can discharge the cleaning liquid CL under pressure. In this embodiment, a syringe is used. As the cleaning liquid CL, a liquid in which cells are not destroyed by osmotic pressure can be used. For example, physiological saline is preferably used.

また、濾過器3の周壁3dの上流側部分に、前記腹水導入ポート3aが設けられており、周壁3dにおける、腹水導入ポート3aよりも下流側の部分に、洗浄廃液CWを濾過器3から排出する洗浄廃液排出ポート3eが設けられている。すなわち、洗浄廃液排出ポート3eは、濾過器3と洗浄液導入ポート3cとを接続する洗浄液導入ポート3cよりも下流側の部分に設けられている。濾過器3の洗浄廃液排出ポート3eは、洗浄廃液回収路を形成する洗浄廃液回収チューブ41を介して洗浄廃液回収容器11に接続されている。洗浄廃液回収チューブ41の中途には、開放弁42が設けられている。   Further, the ascites introduction port 3a is provided in the upstream side portion of the peripheral wall 3d of the filter 3, and the washing waste liquid CW is discharged from the filter 3 to the downstream side of the ascites introduction port 3a in the peripheral wall 3d. A cleaning waste liquid discharge port 3e is provided. That is, the cleaning waste liquid discharge port 3e is provided at a portion downstream of the cleaning liquid introduction port 3c that connects the filter 3 and the cleaning liquid introduction port 3c. The cleaning waste liquid discharge port 3e of the filter 3 is connected to the cleaning waste liquid recovery container 11 via a cleaning waste liquid recovery tube 41 that forms a cleaning waste liquid recovery path. An open valve 42 is provided in the middle of the cleaning waste liquid collection tube 41.

図2に詳細に示すように、濾過器3の洗浄液導入ポート3cは、濾過器3の上流端部に設けた接続用突起に形成された、中空糸膜35の長手方向Xに平行に延びる貫通孔3caからなる。同様に、腹水排出ポート3bは、濾過器3の下流端部に設けた接続用突起に形成された、中空糸膜35の長手方向Xに沿って延びる貫通孔3baからなる。一方、腹水導入ポート3aおよび洗浄廃液排出ポート3eは、それぞれ、濾過器3の周壁3dの上流側部分および下流側部分にそれぞれ設けた、接続用突起に形成された貫通孔3aaおよび3eaからなる。腹水導入ポート3aおよび洗浄廃液排出ポート3eの貫通孔3aaおよび3eaは、それぞれ、中空糸膜35の長手方向Xとほぼ直交する向きに延びるように形成されている。   As shown in detail in FIG. 2, the cleaning liquid introduction port 3 c of the filter 3 is a through-hole extending in parallel to the longitudinal direction X of the hollow fiber membrane 35 formed in the connection protrusion provided at the upstream end of the filter 3. It consists of holes 3ca. Similarly, the ascites discharge port 3b is composed of a through hole 3ba formed along a longitudinal direction X of the hollow fiber membrane 35 formed in a connection projection provided at the downstream end of the filter 3. On the other hand, the ascites introduction port 3a and the washing waste liquid discharge port 3e are formed of through-holes 3aa and 3ea formed in connection protrusions provided in the upstream portion and the downstream portion of the peripheral wall 3d of the filter 3, respectively. The through holes 3aa and 3ea of the ascites introduction port 3a and the washing waste liquid discharge port 3e are formed so as to extend in a direction substantially orthogonal to the longitudinal direction X of the hollow fiber membrane 35, respectively.

濾過器ハウジング33内の、洗浄液導入ポート3cと腹水導入ポート3aとの間の軸方向位置に、多数の中空糸膜35の一方の開放端部(第1端部)35aを固定かつ結束する円板状の第1端部固定部材43が設けられている。また、腹水排出ポート3bと洗浄廃液排出ポート3eとの間の軸方向位置に、多数の中空糸膜の他方の開放端部(第2端部)35bを固定かつ結束する円板状の第2端部固定部材45が設けられている。これら固定部材43および45によって、濾過器3内に、第1端部固定部材43よりも洗浄液導入ポート3c寄りの洗浄液導入空間47、両固定部材43,45間の濾過空間49、および第2端部固定部材45よりも腹水排出ポート3bの濾過腹水排出空間51が画定されている。   A circle for fixing and binding one open end portion (first end portion) 35a of many hollow fiber membranes 35 in the axial direction between the cleaning liquid introduction port 3c and the ascites introduction port 3a in the filter housing 33. A plate-like first end fixing member 43 is provided. In addition, a disk-shaped second member that fixes and binds the other open ends (second ends) 35b of the multiple hollow fiber membranes at an axial position between the ascites discharge port 3b and the cleaning waste liquid discharge port 3e. An end fixing member 45 is provided. By these fixing members 43 and 45, the cleaning liquid introduction space 47 closer to the cleaning liquid introduction port 3c than the first end fixing member 43, the filtration space 49 between the fixing members 43 and 45, and the second end are provided in the filter 3. The filtration ascites discharge space 51 of the ascites discharge port 3b is defined more than the part fixing member 45.

図1の濃縮器5は、濾過腹水A2から、有用物質であるアルブミン等を含まない水を廃液Wとして除去し、濾過腹水A2の有用物質濃度を高めるための装置である。濃縮器5としては、分子量が6.6万程度であるアルブミンを含む濾過腹水A2から、水および水に溶解した電解質のみを分離して排出することのできるものであればどのようなものを用いてもよいが、本実施形態においては、樹脂製の筒状の濃縮器ハウジング55内に、濾過部材として分画分子量が約5000以下の中空糸膜57を収容したものを用いている。   The concentrator 5 of FIG. 1 is an apparatus for removing the water that does not contain albumin or the like, which is a useful substance, from the filtered ascites A2 as waste liquid W and increasing the useful substance concentration in the filtered ascites A2. Any concentrator 5 may be used as long as it can separate and discharge only water and an electrolyte dissolved in water from filtered ascites A2 containing albumin having a molecular weight of about 66,000. However, in the present embodiment, a hollow concentrator housing 55 made of resin contains a hollow fiber membrane 57 having a molecular weight cut off of about 5000 or less as a filtering member.

濃縮器5に使用する濾過部材としては、中空糸膜57のほかに平膜を用いることもできるが、目詰まりを起こしにくい多孔性の中空糸膜が好ましく用いられる。濃縮器5に使用する中空糸膜57の素材としては、実用性のある強度及び耐久性を有する濃縮膜を得ることができることから、ポリスルホン、ポリアクリロニトリル、ポリエチレン、ポリプロピレン、ポリビニルアルコール、エチレン−ビニルアルコール共重合体などが好ましく使用できる。   As a filtration member used in the concentrator 5, a flat membrane can be used in addition to the hollow fiber membrane 57, but a porous hollow fiber membrane that is less likely to be clogged is preferably used. As the material of the hollow fiber membrane 57 used in the concentrator 5, a concentrated membrane having practical strength and durability can be obtained, so that polysulfone, polyacrylonitrile, polyethylene, polypropylene, polyvinyl alcohol, ethylene-vinyl alcohol A copolymer or the like can be preferably used.

廃液吸引装置21としては、任意に吸引圧を設定でき、かつ、設定した圧力を一定に保つことができるものが好ましい。病院施設に一般的に設置されている壁掛け式吸引器を用いることも可能であり、その場合、−300〜−400mmHg程度に吸引圧を設定して良好に濃縮器5からの排水処理を行うことができる。   The waste liquid suction device 21 is preferably one that can arbitrarily set the suction pressure and can keep the set pressure constant. It is also possible to use a wall-mounted suction device that is generally installed in a hospital facility. In that case, the suction pressure is set to about -300 to -400 mmHg and the wastewater treatment from the concentrator 5 is performed well. Can do.

貯留容器13および回収容器15は、患者から採取した腹水A1または濃縮腹水A3を無菌的に貯留することができるものであって、患者から採取した腹水A1および濃縮腹水A3を変性させたり、これらの中に有害な物質が溶出しないもので、かつ、滅菌可能なものであればその材質および形状には制限はない。一般的に、塩化ビニル系やポリプロピレン、ポリエチレン等の軟質材質による輸液バッグで、貯留容器13としては3〜4L程度、回収容器15としては1〜2L程度の容量のものが好ましく使用される。   The storage container 13 and the collection container 15 can aseptically store the ascites A1 or the concentrated ascites A3 collected from the patient, and denature the ascites A1 and the concentrated ascites A3 collected from the patient. There are no restrictions on the material and shape as long as harmful substances do not elute inside and can be sterilized. In general, an infusion bag made of a soft material such as vinyl chloride, polypropylene, or polyethylene, preferably having a capacity of about 3 to 4 L as the storage container 13 and about 1 to 2 L as the collection container 15.

洗浄廃液回収容器11は、洗浄廃液CW中のガン細胞を無菌的に貯留することができるものであって、洗浄廃液CW中に有害な物質が溶出せず、かつ、滅菌可能なものであればその材質および形状には制限はない。一般的に、塩化ビニル系やポリプロピレン、ポリエチレン等の軟質材質による輸液バッグで、3〜4L程度の容量のものが好ましく使用される。   The cleaning waste liquid collection container 11 is capable of aseptically storing cancer cells in the cleaning waste liquid CW, as long as no harmful substances are eluted in the cleaning waste liquid CW and can be sterilized. There are no restrictions on the material and shape. Generally, an infusion bag made of a soft material such as vinyl chloride, polypropylene, or polyethylene, and having a capacity of about 3 to 4 L is preferably used.

陰圧発生装置27は、濃縮器5の中空糸膜57の目詰まりを抑制するために設けられている。陰圧発生装置27は、任意に流量を設定して陰圧を発生させることができ、また設定した流量を一定に保つことができるものが好ましく、病院施設に一般的に設置されている輸液ポンプを使用することが可能である。もっとも、陰圧発生装置27は省略してもよい。   The negative pressure generator 27 is provided to prevent clogging of the hollow fiber membrane 57 of the concentrator 5. The negative pressure generating device 27 is preferably an infusion pump that is capable of generating a negative pressure by arbitrarily setting a flow rate and that can maintain the set flow rate constant, and is generally installed in a hospital facility. Can be used. However, the negative pressure generator 27 may be omitted.

遮断器7は、必要に応じて第2連通チューブ19を確実に閉塞し、第2連通チューブ19によって形成される濾過腹水A2の移送路を遮断することができる部材であればどのようなものでもよく、本実施形態では樹脂製のチューブクランプを用いている。遮断器7としては、チューブクランプのように、第2連通チューブ19と別体で、第2連通チューブ19を外方から挟むことによりこのチューブを閉塞する部材を用いてもよいが、第2連通チューブ19の中途に流路開閉弁を設けてもよい。   The circuit breaker 7 may be any member as long as it can reliably block the second communication tube 19 as necessary and can block the transfer path of the filtered ascites A2 formed by the second communication tube 19. In this embodiment, a resin tube clamp is used. As the circuit breaker 7, a member that is separate from the second communication tube 19 and closes the second communication tube 19 from the outside, such as a tube clamp, may be used. A flow path opening / closing valve may be provided in the middle of the tube 19.

次に、本実施形態に係る腹水処理システム1の動作について説明する。   Next, the operation of the ascites treatment system 1 according to the present embodiment will be described.

図1に示す腹水処理システム1の通常動作状態において、洗浄液導入チューブ37の開放弁39は閉じられており、かつ、第2連通チューブ19は遮断器7によって遮断されていない。この状態で、貯留容器13、第1連通チューブ17、濾過器3、第2連通チューブ19、濃縮器5、および回収チューブ25によって形成される腹水処理通路59内は、陰圧発生装置27および廃液吸引装置21を起動することにより、陰圧状態となる。この陰圧により、貯留容器13内の腹水A1が、腹水導入ポート3aを介して濾過器3に導入される。濾過器3では、腹水A1中のがん細胞などの有害物質が、除去物質61として中空糸膜35によって除去され、中空糸膜35の外表面に付着する。一方、濾過器3で濾過された有用物質であるアルブミン、グロブリン等を含む濾過腹水A2は、腹水排出ポート3bから排出される。   In the normal operation state of the ascites treatment system 1 shown in FIG. 1, the opening valve 39 of the cleaning liquid introduction tube 37 is closed, and the second communication tube 19 is not blocked by the circuit breaker 7. In this state, the inside of the ascites treatment passage 59 formed by the storage container 13, the first communication tube 17, the filter 3, the second communication tube 19, the concentrator 5, and the recovery tube 25 has a negative pressure generator 27 and waste liquid. By starting the suction device 21, a negative pressure state is established. Due to this negative pressure, ascites A1 in the storage container 13 is introduced into the filter 3 through the ascites introduction port 3a. In the filter 3, harmful substances such as cancer cells in the ascites A <b> 1 are removed by the hollow fiber membrane 35 as the removal substance 61 and adhere to the outer surface of the hollow fiber membrane 35. On the other hand, the filtered ascites A2 containing albumin, globulin and the like, which are useful substances filtered by the filter 3, is discharged from the ascites discharge port 3b.

濾過器3から排出された濾過腹水A2は、次に、濃縮器5に導入される。濃縮器5の内部では、濾過腹水A2が中空糸膜57の内側を通過する。このとき、濾過腹水A2の、アルブミン等の有用物質を含まない水の一部が、廃液ポート5bに連通している廃液吸引装置21によって吸引されて、廃液Wとして廃液ポート5bから排出される。濾過腹水A2の廃液Wが除かれた部分は、濃縮腹水A3として、回収ポート5cから排出されて回収容器15に回収される。   The filtered ascites A2 discharged from the filter 3 is then introduced into the concentrator 5. Inside the concentrator 5, the filtered ascites A2 passes inside the hollow fiber membrane 57. At this time, a part of the filtered ascites A2 which does not contain a useful substance such as albumin is sucked by the waste liquid suction device 21 communicating with the waste liquid port 5b and discharged from the waste liquid port 5b as the waste liquid W. The portion of the filtered ascites A2 from which the waste liquid W has been removed is discharged as a concentrated ascites A3 from the collection port 5c and collected in the collection container 15.

腹水処理システム1の洗浄時には、まず、開放弁18が閉じられて第1連通チューブ17が遮断されるとともに、第2連通チューブ19が遮断器7によって遮断される。次いで、洗浄液導入チューブ37の開放弁39、および洗浄廃液回収チューブ41の開放弁42が開かれ、その後、洗浄液供給器9によって洗浄液CLが濾過器3に供給される。濾過器3に供給された洗浄液CLは、図2に示すように、洗浄液導入空間47から中空糸膜35の内側に流入する。このとき、第2連通チューブ19が遮断器7によって閉塞されているので、洗浄液CLは、図3に示すように、シリンジである洗浄液供給器9によって付与された圧力により、中空糸膜35表面の孔35cを通って、中空糸膜35の内部から外部へ流出する。この洗浄液CLによって、除去物質61が中空糸膜35の外表面から剥離し、洗浄液CLとともに、図1の洗浄廃液回収容器11に、洗浄廃液CWとして回収される。   When cleaning the ascites treatment system 1, first, the open valve 18 is closed to block the first communication tube 17, and the second communication tube 19 is blocked by the circuit breaker 7. Next, the opening valve 39 of the cleaning liquid introduction tube 37 and the opening valve 42 of the cleaning waste liquid recovery tube 41 are opened, and then the cleaning liquid CL is supplied to the filter 3 by the cleaning liquid supplier 9. As shown in FIG. 2, the cleaning liquid CL supplied to the filter 3 flows from the cleaning liquid introduction space 47 into the hollow fiber membrane 35. At this time, since the second communication tube 19 is closed by the circuit breaker 7, the cleaning liquid CL is applied to the surface of the hollow fiber membrane 35 by the pressure applied by the cleaning liquid supplier 9 as a syringe, as shown in FIG. It flows out from the inside of the hollow fiber membrane 35 through the hole 35c. With this cleaning liquid CL, the removal substance 61 is peeled off from the outer surface of the hollow fiber membrane 35 and is recovered as a cleaning waste liquid CW in the cleaning waste liquid recovery container 11 of FIG.

本実施形態に係る腹水処理システム1によれば、濾過器3を短時間で、かつ容易に洗浄することができるので、長時間にわたって継続的に大量の腹水を処理することが可能となる。実験によれば、13リットルの腹水を、1リットル当り約7分で処理できることが確認された。さらには、細胞成分や粘液成分を多く含む腹水や血性腹水を処理することも可能となる。また、濾過器3の洗浄によって回収された除去物質61に含まれるガン細胞は、免疫療法や抗がん剤感受性テストに利用できる可能性がある。   According to the ascites treatment system 1 according to the present embodiment, since the filter 3 can be easily washed in a short time, a large amount of ascites can be treated continuously for a long time. Experiments have confirmed that 13 liters of ascites can be treated in about 7 minutes per liter. Furthermore, it becomes possible to treat ascites and bloody ascites containing a large amount of cell components and mucus components. In addition, cancer cells contained in the removed substance 61 collected by washing the filter 3 may be used for immunotherapy and anticancer drug sensitivity tests.

以上のとおり、図面を参照しながら本発明の好適な実施形態を説明したが、本発明の趣旨を逸脱しない範囲内で、種々の追加、変更または削除が可能である。したがって、そのようなものも本発明の範囲内に含まれる。   As described above, the preferred embodiments of the present invention have been described with reference to the drawings, but various additions, modifications, or deletions can be made without departing from the spirit of the present invention. Therefore, such a thing is also included in the scope of the present invention.

1 腹水処理システム
3 濾過器
3a 洗浄液供給ポート
3b 腹水排出ポート
3e 洗浄廃液排出ポート
5 濃縮器
7 遮断器
9 洗浄液供給器
11 洗浄廃液回収容器
35 中空糸膜(濾過部材)
61 除去物質
A1 腹水
A2 濾過腹水
CL 洗浄液
CW 洗浄廃液
DESCRIPTION OF SYMBOLS 1 Ascites treatment system 3 Filter 3a Cleaning liquid supply port 3b Ascites discharge port 3e Cleaning waste liquid discharge port 5 Concentrator 7 Circuit breaker 9 Cleaning liquid supply 11 Cleaning waste liquid collection container 35 Hollow fiber membrane (filter member)
61 Substances to be removed A1 Ascites A2 Filtration ascites CL Cleaning fluid CW Cleaning waste fluid

Claims (4)

腹水中の特定の物質を選択的に除去する濾過部材を備える濾過器と、
前記濾過器の腹水排出ポートに濾過腹水移送路を介して接続し、前記濾過器で濾過された濾過腹水を濾過して濃縮する濃縮器と、
を備え、
前記濾過器は、前記濾過腹水移送路が遮断された該腹水処理システムの洗浄時に、外部から濾過部材に洗浄液が供給される洗浄液供給ポートと、前記濾過部材によって選択的に除去された物質を前記洗浄時に前記洗浄液とともに排出する洗浄廃液排出ポートとを有する腹水処理システム。
A filter comprising a filtering member for selectively removing specific substances in ascites;
A concentrator that connects to the ascites discharge port of the filter through a filter ascites transfer path, and filters and concentrates the filtered ascites filtered by the filter;
With
The filter includes a cleaning liquid supply port through which a cleaning liquid is supplied from the outside to the filtering member during cleaning of the ascites treatment system in which the filtration ascites transfer path is blocked, and a substance selectively removed by the filtering member. An ascites treatment system having a cleaning waste liquid discharge port for discharging together with the cleaning liquid during cleaning.
請求項1において、前記濾過器の前記濾過部材が中空糸膜であり、外圧方式で両端が開口した中空糸膜の一端部が腹水処理時に閉塞される前記洗浄液供給ポートに連通しており、他端部が前記腹水排出ポートに連通している腹水処理システム。   In Claim 1, the said filtration member of the said filter is a hollow fiber membrane, and the one end part of the hollow fiber membrane which both ends opened by the external pressure system is connected to the said washing | cleaning liquid supply port obstruct | occluded at the time of ascites treatment, An ascites treatment system having an end communicating with the ascites discharge port. 請求項1または2において、さらに、前記洗浄時に、前記濾過器に前記洗浄液を供給する洗浄液供給器と、前記濾過器から排出された前記洗浄廃液を回収する洗浄廃液回収容器とを有する腹水処理システム。   The ascites treatment system according to claim 1, further comprising a cleaning liquid supplier that supplies the cleaning liquid to the filter during the cleaning, and a cleaning waste liquid recovery container that recovers the cleaning waste liquid discharged from the filter. . 請求項1から3のいずれか一項に記載の腹水処理システムを洗浄する方法であって、
前記濾過腹水移送路を遮断することと、
前記濾過器に外部から前記洗浄液を供給することと、
前記濾過部材によって選択的に除去された物質を、前記洗浄液とともに排出することと、
を含む腹水処理システムの洗浄方法。
A method for cleaning the ascites treatment system according to any one of claims 1 to 3,
Blocking the filtration ascites transfer path;
Supplying the cleaning liquid from the outside to the filter;
Discharging the substance selectively removed by the filter member together with the cleaning liquid;
A method for cleaning an ascites treatment system.
JP2010040109A 2010-02-25 2010-02-25 Ascites treatment system and cleaning method thereof Active JP5249973B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010040109A JP5249973B2 (en) 2010-02-25 2010-02-25 Ascites treatment system and cleaning method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010040109A JP5249973B2 (en) 2010-02-25 2010-02-25 Ascites treatment system and cleaning method thereof

Publications (2)

Publication Number Publication Date
JP2011172797A true JP2011172797A (en) 2011-09-08
JP5249973B2 JP5249973B2 (en) 2013-07-31

Family

ID=44686246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010040109A Active JP5249973B2 (en) 2010-02-25 2010-02-25 Ascites treatment system and cleaning method thereof

Country Status (1)

Country Link
JP (1) JP5249973B2 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013176140A1 (en) * 2012-05-25 2013-11-28 旭化成メディカル株式会社 Method and apparatus for producing high-concentration protein solution
JP2014064805A (en) * 2012-09-26 2014-04-17 Asahi Kasei Corp Ascites treatment system
WO2014112352A1 (en) * 2013-01-15 2014-07-24 国立大学法人徳島大学 Stock solution concentrating device, stock solution treatment device, and circulation-type treatment device
JP2015126763A (en) * 2013-12-27 2015-07-09 旭化成メディカル株式会社 Ascites filtration concentration system, method for cleaning filter and concentrator in ascites filtration concentration system, and method for recovering filtrate and concentrated liquid in cleaning filter and concentrator
WO2016060209A1 (en) * 2014-10-16 2016-04-21 旭化成メディカル株式会社 Body fluid filtration device of hollow fiber membrane type, and method for filtrating protein solution
WO2016111320A1 (en) * 2015-01-07 2016-07-14 旭化成メディカル株式会社 Filter, coelomic fluid processing system, and coelomic fluid processing method
JP2018050502A (en) * 2016-09-27 2018-04-05 米満 吉和 Apparatus for aseptically treating suspension liquid
WO2018212354A1 (en) * 2017-05-19 2018-11-22 国立大学法人徳島大学 Stock solution treatment device, and operation method for stock solution treatment device
JP2019013488A (en) * 2017-07-07 2019-01-31 旭化成メディカル株式会社 Coelomic fluid treatment device
JP2019013487A (en) * 2017-07-07 2019-01-31 旭化成メディカル株式会社 Coelomic fluid treatment device
JP2019084455A (en) * 2017-07-07 2019-06-06 旭化成メディカル株式会社 Coelomic fluid treatment device
JP2019134984A (en) * 2017-07-07 2019-08-15 旭化成メディカル株式会社 Coelomic fluid treatment device
JP2021164719A (en) * 2019-05-22 2021-10-14 旭化成メディカル株式会社 Coelomic fluid treatment device
JP2021164730A (en) * 2019-03-18 2021-10-14 旭化成メディカル株式会社 Coelomic fluid treatment device
WO2023090428A1 (en) * 2021-11-19 2023-05-25 ニプロ株式会社 Coelomic fluid processing system

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5226379A (en) * 1975-08-25 1977-02-26 Asahi Chem Ind Co Ltd Method of washing ultrafiltration membranes
JPS5516674A (en) * 1978-07-24 1980-02-05 Kuraray Co Abdominal dropsy treatment device
JPS5731867A (en) * 1980-08-04 1982-02-20 Kuraray Co Concentrating filtering device for body fluid
JPS5775658A (en) * 1980-10-31 1982-05-12 Nippon Medical Supply Washing of artificial kindey
JPS58177660A (en) * 1982-04-14 1983-10-18 旭メデイカル株式会社 Priming method
JPS6032897A (en) * 1983-08-03 1985-02-20 旭化成株式会社 Dewaxing device
JPS6115701B2 (en) * 1980-03-28 1986-04-25 Terumo Corp
JPS62502317A (en) * 1985-03-28 1987-09-10 メムテック・リミテッド Cooled hollow fiber - cross flow type separator
JPH025963A (en) * 1988-06-25 1990-01-10 Terumo Corp Manufacture of blood plasma separator
JPH025965A (en) * 1988-06-27 1990-01-10 Asahi Medical Co Ltd Blood purifying device
JPH0341958A (en) * 1989-07-10 1991-02-22 Terumo Corp Device and method for washing medical instrument
JPH046879Y2 (en) * 1988-06-03 1992-02-25
JPH09262444A (en) * 1996-03-29 1997-10-07 Toray Ind Inc Cleaning method of membrane module
JP2000233020A (en) * 1999-02-15 2000-08-29 Nikkiso Co Ltd Washing method and washing device for blood treating device
JP3548736B2 (en) * 2001-09-03 2004-07-28 住友重機械工業株式会社 Backwashing method of separation membrane
JP3704544B2 (en) * 1994-09-09 2005-10-12 ユー・エス・フィルター・ウェイストウォーター・グループ・インコーポレイテッド Cleaning of hollow fiber membranes
JP4183036B2 (en) * 2003-06-19 2008-11-19 メディカルサイエンス株式会社 Blood purification apparatus and regeneration method thereof

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5226379A (en) * 1975-08-25 1977-02-26 Asahi Chem Ind Co Ltd Method of washing ultrafiltration membranes
JPS5516674A (en) * 1978-07-24 1980-02-05 Kuraray Co Abdominal dropsy treatment device
JPS6115701B2 (en) * 1980-03-28 1986-04-25 Terumo Corp
JPS5731867A (en) * 1980-08-04 1982-02-20 Kuraray Co Concentrating filtering device for body fluid
JPS5775658A (en) * 1980-10-31 1982-05-12 Nippon Medical Supply Washing of artificial kindey
JPS58177660A (en) * 1982-04-14 1983-10-18 旭メデイカル株式会社 Priming method
JPS6032897A (en) * 1983-08-03 1985-02-20 旭化成株式会社 Dewaxing device
JPS62502317A (en) * 1985-03-28 1987-09-10 メムテック・リミテッド Cooled hollow fiber - cross flow type separator
JPH046879Y2 (en) * 1988-06-03 1992-02-25
JPH025963A (en) * 1988-06-25 1990-01-10 Terumo Corp Manufacture of blood plasma separator
JPH025965A (en) * 1988-06-27 1990-01-10 Asahi Medical Co Ltd Blood purifying device
JPH0341958A (en) * 1989-07-10 1991-02-22 Terumo Corp Device and method for washing medical instrument
JP3704544B2 (en) * 1994-09-09 2005-10-12 ユー・エス・フィルター・ウェイストウォーター・グループ・インコーポレイテッド Cleaning of hollow fiber membranes
JPH09262444A (en) * 1996-03-29 1997-10-07 Toray Ind Inc Cleaning method of membrane module
JP2000233020A (en) * 1999-02-15 2000-08-29 Nikkiso Co Ltd Washing method and washing device for blood treating device
JP3548736B2 (en) * 2001-09-03 2004-07-28 住友重機械工業株式会社 Backwashing method of separation membrane
JP4183036B2 (en) * 2003-06-19 2008-11-19 メディカルサイエンス株式会社 Blood purification apparatus and regeneration method thereof

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104334201A (en) * 2012-05-25 2015-02-04 旭化成医疗株式会社 Method and apparatus for producing high-concentration protein solution
JPWO2013176140A1 (en) * 2012-05-25 2016-01-14 旭化成メディカル株式会社 Method and apparatus for producing high concentration protein solution
WO2013176140A1 (en) * 2012-05-25 2013-11-28 旭化成メディカル株式会社 Method and apparatus for producing high-concentration protein solution
CN104334201B (en) * 2012-05-25 2016-06-15 旭化成医疗株式会社 The manufacture method of high concentration protein solution and manufacturing installation
TWI568461B (en) * 2012-05-25 2017-02-01 Asahi Kasei Medical Co Ltd Method for producing high concentration protein solution and manufacturing device thereof
JP2014064805A (en) * 2012-09-26 2014-04-17 Asahi Kasei Corp Ascites treatment system
JPWO2014112352A1 (en) * 2013-01-15 2017-01-19 国立大学法人徳島大学 Stock solution concentrator, stock solution processing device, and circulation type processing device
WO2014112352A1 (en) * 2013-01-15 2014-07-24 国立大学法人徳島大学 Stock solution concentrating device, stock solution treatment device, and circulation-type treatment device
JP5800099B2 (en) * 2013-01-15 2015-10-28 国立大学法人徳島大学 Stock solution concentrator, stock solution processing device, and circulation type processing device
JP2015126763A (en) * 2013-12-27 2015-07-09 旭化成メディカル株式会社 Ascites filtration concentration system, method for cleaning filter and concentrator in ascites filtration concentration system, and method for recovering filtrate and concentrated liquid in cleaning filter and concentrator
CN106794287B (en) * 2014-10-16 2019-09-10 旭化成医疗株式会社 The filter method of hollow fiber membrane-type body fluid filter device and protein solution
WO2016060209A1 (en) * 2014-10-16 2016-04-21 旭化成メディカル株式会社 Body fluid filtration device of hollow fiber membrane type, and method for filtrating protein solution
CN106794287A (en) * 2014-10-16 2017-05-31 旭化成医疗株式会社 The filter method of hollow fiber membrane-type body fluid filter and protein solution
JPWO2016060209A1 (en) * 2014-10-16 2017-06-29 旭化成メディカル株式会社 Hollow fiber membrane type body fluid filtration device and protein solution filtration method
TWI584868B (en) * 2015-01-07 2017-06-01 Asahi Kasei Medical Co Ltd Filter, body fluid treatment system and body cavity fluid treatment method
CN106999855A (en) * 2015-01-07 2017-08-01 旭化成医疗株式会社 Filter, body cavity liquid treating system and body cavity liquid processing method
JPWO2016111320A1 (en) * 2015-01-07 2017-08-31 旭化成メディカル株式会社 Filter, body cavity fluid processing system, and body cavity fluid processing method
WO2016111320A1 (en) * 2015-01-07 2016-07-14 旭化成メディカル株式会社 Filter, coelomic fluid processing system, and coelomic fluid processing method
CN106999855B (en) * 2015-01-07 2019-09-20 旭化成医疗株式会社 Filter, body cavity liquid treating system and body cavity liquid processing method
JP2018050502A (en) * 2016-09-27 2018-04-05 米満 吉和 Apparatus for aseptically treating suspension liquid
WO2018062075A1 (en) * 2016-09-27 2018-04-05 米満 吉和 Tool for aseptically treating suspension
JP6989907B2 (en) 2016-09-27 2022-02-15 吉和 米満 A device for aseptically processing suspensions
WO2018212354A1 (en) * 2017-05-19 2018-11-22 国立大学法人徳島大学 Stock solution treatment device, and operation method for stock solution treatment device
JP2019013487A (en) * 2017-07-07 2019-01-31 旭化成メディカル株式会社 Coelomic fluid treatment device
JP2019134984A (en) * 2017-07-07 2019-08-15 旭化成メディカル株式会社 Coelomic fluid treatment device
JP2019084455A (en) * 2017-07-07 2019-06-06 旭化成メディカル株式会社 Coelomic fluid treatment device
JP2019013488A (en) * 2017-07-07 2019-01-31 旭化成メディカル株式会社 Coelomic fluid treatment device
CN114053507A (en) * 2017-07-07 2022-02-18 旭化成医疗株式会社 Body cavity liquid treatment device
JP2021164730A (en) * 2019-03-18 2021-10-14 旭化成メディカル株式会社 Coelomic fluid treatment device
JP7096411B2 (en) 2019-03-18 2022-07-05 旭化成メディカル株式会社 Body cavity fluid treatment device
JP2021164719A (en) * 2019-05-22 2021-10-14 旭化成メディカル株式会社 Coelomic fluid treatment device
JP7096410B2 (en) 2019-05-22 2022-07-05 旭化成メディカル株式会社 Body cavity fluid treatment device
WO2023090428A1 (en) * 2021-11-19 2023-05-25 ニプロ株式会社 Coelomic fluid processing system

Also Published As

Publication number Publication date
JP5249973B2 (en) 2013-07-31

Similar Documents

Publication Publication Date Title
JP5249973B2 (en) Ascites treatment system and cleaning method thereof
JP5062631B2 (en) Ascites treatment system and operating method thereof
JP4091873B2 (en) Dialysis machine
JP6469123B2 (en) Hollow fiber membrane type body fluid filtration device, operation method and filtration method of hollow fiber membrane type body fluid filtration device
JP6230907B2 (en) Ascites filtration and concentration system, filter and concentrator washing method in ascites filtration and concentration system, and filtrate and concentrate recovery method during washing of filter and concentrator
US7140497B2 (en) Selective deleukocytation unit for a platelet product
JPH08500509A (en) Method and apparatus for removing unintended fluids from treated blood products
US11931499B2 (en) Pressure detector
JP2018518241A5 (en)
JP5631731B2 (en) Blood treatment filter
JP2003265601A (en) Blood circuit
JP2001245970A (en) Priming processing method for blood circuit
KR102171036B1 (en) Device for performing a method for conserving a blood treatment device and method for conserving a blood treatment device
JP6671159B2 (en) Blood purification device
JP4297767B2 (en) Blood processing filter system
JP2007236665A (en) Blood component separating apparatus and its usage
JP4183036B2 (en) Blood purification apparatus and regeneration method thereof
JP2007319542A (en) Apparatus and circuit for treatment of hemocyte preparation
JP2012034992A (en) Priming system for blood treater
JPH03173824A (en) Leukocyte separator
JP6473650B2 (en) Blood purification equipment
US11911549B2 (en) Plasmapheresis device
JP6700481B2 (en) Blood purification device and priming method thereof
JPH0263470A (en) Liquid treating device
JP7114466B2 (en) Blood purification device and priming method

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120831

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20120831

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20121105

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121113

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130108

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130402

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130412

R150 Certificate of patent or registration of utility model

Ref document number: 5249973

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160419

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250